Multi-engine structure-based docking and rescoring that prioritizes physically plausible binding modes.
The core workflow combines Vina/Smina sampling with GNINA CNN rescoring
to reduce false positives and produce an audit-ready shortlist for downstream validation.
Optional: integrate ML rescoring (RF/GNN) after docking when you need rank stability across conditions/variants.
If you do not yet have candidates, start from Service — Generation.
| Item | Examples |
|---|---|
| Receptor structure | PDB/mmCIF/AlphaFold model; chain selection; cofactors (if relevant) |
| Candidate library | SMILES/SDF (small molecules) or FASTA/structures (peptides) |
| Docking region | Pocket box (center/size) or residue-defined hotspot region |
| Run policy | Top-k poses, exhaustiveness, rescoring on/off, clustering rules |
If the docking region is not defined, we can derive a first-pass pocket/hotspot definition from the structure.
The objective is not a single “best score.” The objective is a shortlist with physical plausibility and traceable evidence.
Designed to produce outputs that are immediately usable for mechanistic validation, MD simulation, and experimental selection.
Receptor preparation, ligand/peptide preparation, and pocket/hotspot definition.
Vina/Smina sampling with top-k pose extraction, clustering, and rank stability checks.
Compute CNNscore/CNNaffinity and penalize geometrically implausible poses (false-positive reduction).
Deliver ranked shortlist with evidence and handoff sets for interaction analysis, consensus, and MD validation.
Optional residue-level interaction fingerprints (ProLIF-style) can be generated for the top set.
Docking/CNN results can be combined with ML and selection logic to produce a final prioritized list.
MD is recommended for Top-N candidates rather than the full library to control cost and runtime.
Standard flow after Docking:
Mechanistic validation (interaction evidence) → Consensus ranking → MD Simulation (final shortlist).
If the goal is purely triage, Docking + CNN rescoring can be used as a standalone screening service.